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Behavioral/Cognitive

Hippocampal Long-Term Potentiation Is Disrupted during
Expression and Extinction But Is Restored after
Reinstatement of Morphine Place Preference
George S. Portugal,1* Ream Al-Hasani,2,3* Amanda K. Fakira,1* Jose L. Gonzalez -Romero,1 Zare Melyan,1
Jordan G. McCall,2 Michael R. Bruchas,2,3,4 and Jose A. Morón1
1Department of Anesthesiology, College of Physicians and Surgeons, Columbia University, New York, New York 10032, 2Department of Anesthesiology,
Division of Basic Research, 3Department of Anatomy–Neurobiology, and 4Washington University Pain Center, Washington University School of Medicine,
St. Louis, Missouri 63110

Learned associations between environmental cues and morphine use play an important role in the maintenance and/or relapse of opioid
addiction. Although previous studies suggest that context-dependent morphine treatment alters glutamatergic transmission and synaptic plasticity in the hippocampus, their role in morphine conditioned place preference (CPP) and reinstatement remains unknown. We
investigated changes in synaptic plasticity and NMDAR expression in the hippocampus after the expression, extinction, and reinstatement of morphine CPP. Here we report that morphine CPP is associated with increased basal synaptic transmission, impaired hippocampal long-term potentiation (LTP), and increased synaptic expression of the NR1 and NR2b NMDAR subunits. Changes in synaptic
plasticity, synaptic NR1 and NR2b expression, and morphine CPP were absent when morphine was not paired with a specific context.
Furthermore, hippocampal LTP was impaired and synaptic NR2b expression was increased after extinction of morphine CPP, indicating
that these alterations in plasticity may be involved in the mechanisms underlying the learning of drug– environment associations. After
extinction of morphine CPP, a priming dose of morphine was sufficient to reinstate morphine CPP and was associated with LTP that was
indistinguishable from saline control groups. In contrast, morphine CPP extinguished mice that received a saline priming dose did not
show CPP and had disrupted hippocampal LTP. Finally, we found that reinstatement of morphine CPP was prevented by the selective
blockade of the NR2b subunit in the hippocampus. Together, these data suggest that alterations in synaptic plasticity and glutamatergic
transmission play an important role in the reinstatement of morphine CPP.
Key words: CPP; hippocampus; LTP; morphine; NMDA; plasticity

Introduction
Morphine, a widely used opioid analgesic drug, exerts diverse
behavioral and molecular effects. Addiction to morphine and
other opioids is a major public health issue, with 11 million
Americans having engaged in opioid abuse (Compton and
Volkow, 2006). Although significant advances in the treatment of
opioid addiction have been made through the development of
pharmacotherapies (for review, see Bart, 2012), relapse to opioid
use after periods of abstinence continues to impede successful
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treatment, highlighting the need for continued efforts to dissect
the mechanisms of opioid-dependent changes in brain plasticity.
Associations between drug use and the drug administration
environment can lead to cravings that promote continued use
and can facilitate relapse (Daglish et al., 2001; See, 2002). Mice
can develop a conditioned place preference (CPP) in which the
rewarding properties of morphine are paired with a drug administration environment (Kim et al., 1996; Ribeiro Do Couto et al.,
2005; Benturquia et al., 2007; Solecki et al., 2009). This behavior
can be extinguished by pairing the drug-associated context with
saline and then reinstated by a priming dose of morphine (Ribeiro Do Couto et al., 2005). Animal models of morphine addiction have revealed that drug-associated contexts can lead to
changes in glutamatergic signaling (Xia et al., 2011; Fakira et al.,
2013). The administration of NMDA receptor (NMDAR) antagonists can block morphine CPP (Ribeiro Do Couto et al., 2005;
Ma et al., 2007, 2011a; Zarrindast et al., 2007; Li et al., 2011),
suggesting that NMDARs play a critical role in associations between morphine and contextual stimuli.
Evidence suggests that repeated drug treatment can lead to
adaptations in hippocampal synaptic plasticity that may play a
crucial role in drug– context associations. Several forms of syn-
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aptic plasticity in the hippocampal Schaffer collateral–CA1 pathway, such as long-term potentiation (LTP), are dependent on
NMDAR-mediated Ca 2⫹ influx (Muller et al., 1988; Shapiro and
Eichenbaum, 1999; Miyamoto, 2006). Furthermore, previous
morphine CPP studies have demonstrated increased NR2b
NMDAR subunit expression in the hippocampus (Ma et al.,
2006, 2007) and have shown that hippocampal infusions of an
NMDAR antagonist can block morphine CPP (Zarrindast et al.,
2007). Together, these data suggest that NMDAR-mediated signaling in the hippocampus may be crucial for morphine CPP and
may lead to changes in synaptic plasticity (i.e., LTP). Morphineinduced alterations in hippocampal LTP may have consequences
for drug dependence and craving because contextual-driven
memories have been associated with drug craving in abstinent
opioid abusers (Daglish et al., 2001; Ersche et al., 2006; Prosser et
al., 2006). However, few studies have investigated the role of the
hippocampus in morphine CPP and morphine-induced reinstatement, which may provide a new target to prevent relapse. In
addition, no studies have been conducted on the role of NMDAR
on reinstatement of morphine CPP. Thus, in the present study,
we used a multidisciplinary approach to directly investigate the
changes in hippocampal synaptic NMDAR expression, basal synaptic transmission, and LTP after expression, extinction, and reinstatement of morphine CPP. Together, our results identify the
importance of hippocampal synaptic plasticity and NMDAR expression in associations between morphine and environmental
context that ultimately lead to reinstatement of morphine CPP.

Materials and Methods
Subjects
Subjects were 7- to 10-week-old male C57BL/6J mice (25–30 g; Harlan)
that were maintained on a 12 h light/dark cycle and were habituated to
the colony room for 1 week before the start of experiments. All experimental protocols were approved by the Institutional Animal Care and
Use Committee at Columbia University and Washington University
School of Medicine, according to the U.S. Department of Agriculture
Animal Welfare Act (Public Law 89-544) and the National Institutes of
Health Guide for the Care and Use of the Laboratory Animals (Department
of Health, Education, and Welfare Publication 85-23, revised 1985).

Apparatus
CPP to morphine was assessed using four identical conditioning boxes
(63 ⫻ 26 ⫻ 30.5 cm) that contained two chambers for drug conditioning
(26 ⫻ 26 ⫻ 30.5 cm) and a central compartment (8.5 ⫻ 26 ⫻ 30.5 cm)
that was not paired with saline or morphine treatment. The drug conditioning chamber walls had 2.5-cm-wide horizontal or vertical black and
white stripes that were used to distinguish the two chambers from each
other, whereas the walls in the central chamber were made of white
nonreflective plastic. The floors of the two conditioning chambers were
lined with cob bedding (Enrich-O’ Cobs; Andersons Lab Bedding). The
total amount of time spent in all three chambers was determined with an
array of photobeams (Med Associates) that were positioned at the base of
each chamber. Morphine CPP experiments conducted at the Washington University School of Medicine used identical CPP chambers as those
described above, but chamber preference was determined using a video
tracking system (Ethovision; Noldus).

Drug administration
Morphine sulfate (National Institute on Drug Abuse Drug Program or
Sigma-Aldrich) was dissolved in saline at the concentration of 1 mg/ml.
For all morphine CPP experiments, mice were injected subcutaneously
with daily escalating doses of morphine (5, 8, 10, and 15 mg/kg) or
equivalent volume of saline and then immediately placed in the conditioning chamber. Animals were killed immediately after either morphine
CPP (24 h after the final morphine injection), extinction of morphine
CPP (7 d after morphine treatment), or reinstatement of morphine CPP
(8 d after initial morphine treatment and 15 min after morphine rein-

statement injection). After each of these tests, hippocampi were immediately dissected and either used for electrophysiological experiments or
stored flash frozen at ⫺80°C until use.

Cannulae implantation surgical procedure
After acclimatizing to the holding facility for 7 to 9 d, the animals were
anesthetized in an induction chamber (4% isoflurane) and mounted on a
stereotaxic frame under sterile conditions (model 1900; David Kopf Instruments) in which they were maintained at 1–2% isoflurane for the
duration of the surgery. A craniotomy was performed, and two cannulae
(C315G/SPC, 1.5 mm; Plastics One) were lowered bilaterally into the
hippocampus (⫺1.7 mm anteroposterior; ⫾1.5 mm mediolateral; ⫺1.8
mm dorsoventral from bregma; Shirayama et al., 2004; Land et al., 2009;
Knoll et al., 2011; Smith et al., 2012). The cannulae were secured using
two bone screws (catalog #743102; CMA/Microdialysis) and affixed with
dental cement (Lang Dental). Mice were allowed to recover for at least 7 d
before behavioral testing.
To confirm cannulae placement, immunohistochemistry was performed as described previously (Bruchas et al., 2007a,b; Land et al., 2008;
Lemos et al., 2011; Al-Hasani et al., 2013b). Mice were anesthetized with
pentobarbital and perfused intracardially with ice-cold 4% paraformaldehyde in phosphate buffer (PB). Brains were dissected, postfixed 24 h at
4°C, cryoprotected with a solution of 30% sucrose in 0.1 M PB at 4°C for
at least 24 h, cut into 30 m sections, and processed for immunostaining.
Sections were washed twice in PBS and blocked in PBS containing 0.1%
Triton X-100 (TX-100; G-Biosciences) for 10 min, followed by an 1 h
incubation with fluorescent Nissl stain (1:400; Neurotrace; Invitrogen).
Sections were then washed twice in PBS and mounted on glass slides with
hard set Vectashield (Vector Laboratories). All sections were imaged with
an epifluorescent microscope (Olympus BX61) in the Washington University Pain Center.

Experimental design
Handling and habituation. As described previously (Portugal and Gould,
2009), before all experiments, mice were habituated for 3 d (6 h/d) to the
room in which behavioral experiments would occur, and each mouse was
handled twice daily. During handling sessions, mice were gently restrained as though in preparation for a subcutaneous injection and were
released after several seconds. This process was repeated for ⬃1 min, and
then mice were returned to the home cage. Mice that exhibited signs of
increased anxiety (i.e., shaking, vocalizations) received additional handling sessions until signs of anxiety were reduced.
Morphine CPP. At the start of morphine CPP training, initial preferences for the three chambers were determined in a 15 min preconditioning session, in which mice were placed in the central chamber and
allowed to explore all three chambers (for a schematic of the experiment,
see Fig. 1A). Mice exhibited no initial preference (bias) for the horizontal
or vertical striped chamber (t(64) ⫽ 1.51; p ⬎ 0.05), and therefore the
morphine-paired chamber was randomly assigned for each mouse in the
morphine CPP group, in a counterbalanced unbiased manner. After preconditioning (pretest), mice received eight conditioning sessions (four
morning and four evening sessions; Land et al., 2009; Bruchas et al., 2011;
Einstein et al., 2013). During conditioning, mice in the morphine test
group received a subcutaneous injection of saline in the morning and
were immediately confined to one chamber (saline-paired conditioning
chamber) for 30 min. Four hours later, in the afternoon, mice in the
morphine CPP group received a subcutaneous injection of morphine
and were immediately confined to the other chamber (morphine-paired
conditioning chamber) for 30 min. In contrast, mice in the saline CPP
group received saline during both conditioning sessions. To rule out the
effects of 24 h withdrawal from morphine treatment on NMDAR expression and synaptic plasticity, a morphine-unpaired group was included in
which morphine was administered alternately in both conditioning
chambers during the afternoon conditioning sessions. For the morphineunpaired control group, the location of morphine administration was
alternated between days (i.e., horizontal chamber in the afternoon on day
1, vertical chamber in the afternoon on day 2), and thus any changes in
NMDAR expression and synaptic plasticity observed in morphineunpaired mice could not be attributable to an association between mor-
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Figure 1. Morphine CPP is associated with increased basal synaptic transmission and impaired LTP. A, A schematic of the experimental design is shown for the training and testing of morphine
CPP. B, Treatment with escalating doses of morphine produces CPP. Mice treated with escalating doses of morphine-paired with a novel context (morphine-paired group) exhibited a significant
increase in preference for the morphine-paired chamber relative to saline-treated mice (saline group) and mice that received morphine in both drug conditioning chambers (morphine-unpaired
group; n ⫽ 9 –14 per group; *p ⬍ 0.05). Preference score was determined by subtracting the time spent in the morphine-paired side during preconditioning from the time spent in the
morphine-paired side during testing (expressed as seconds). C, Mice trained and tested for morphine CPP exhibited a significantly enhanced fEPSP slope compared with saline-treated mice (n ⫽ 4
per group; one-way ANOVA; *p ⬍ 0.05, **p ⬍ 0.01). Insets show fEPSP–FV relationships. D, The expression of morphine CPP was associated with disrupted LTP when compared with saline-treated
mice and morphine-unpaired mice (n ⫽ 3– 4 per group; one-way ANOVA; *p ⬍ 0.05). Insets show comparisons of fEPSP slopes during the final 10 min of recording.
phine treatment and a specific drug conditioning chamber. On the test
day (24 h after final morphine injection), mice were placed in the central
chamber and were allowed to explore all three chambers for 15 min. Place
preference scores were calculated as described previously by subtracting
the time spent in the drug-paired side during preconditioning from the
time spent in the drug-paired side during postconditioning (Tzschentke,
2007; Al-Hasani et al., 2013a,b).
Extinction and reinstatement of morphine CPP. Extinction of morphine
CPP commenced 24 h after morphine CPP (for a schematic of this experiment, see Fig. 4A ). Mice in all groups received 10 extinction training
sessions (five morning and five evening sessions), in which a subcutaneous injection of saline was administered and mice were confined to the
saline-paired compartment for 30 min. During afternoon extinction
training, mice received a second subcutaneous injection of saline and
were confined to the morphine-paired chamber for 30 min. Testing of
extinction occurred 24 h after the final conditioning session (7 d after
morphine treatment); mice were placed in the central chamber and allowed to explore all three chambers for 15 min. Preference scores were
calculated in the same manner as described above, and extinction of CPP
was defined as a preference score that was ⬍15% of the initial preference
score. As with the experiments described above, a morphine-unpaired
group was included in extinction experiments to rule out whether
changes in NMDAR expression and synaptic plasticity that could be
attributable to withdrawal from morphine treatment. Mice in the
morphine-unpaired group received morphine in both chambers on alternating days during the training of morphine CPP, and extinction
experiments were conducted in the same manner as described above.
The reinstatement of morphine CPP occurred 24 h after the CPP
extinction test (for a schematic of this experiment, see Fig. 5A). Mice that
showed extinction of morphine CPP or saline controls were treated subcutaneously with 5 mg/kg morphine, placed in the central chamber, and

allowed to explore all three chambers for 15 min. As with previously
described experiments, a third group of mice was included in which
morphine treatment was not paired with the context during CPP training
(morphine-unpaired group). During reinstatement testing, mice in the
morphine-unpaired group were administered 5 mg/kg morphine, placed
in the central chamber, and explored all three chambers for 15 min. A
fourth group of mice was also included that were trained and tested for
both morphine CPP and morphine CPP extinction as described above.
However, during the reinstatement test, mice in this group received subcutaneous saline instead of morphine and were allowed to explore the
three chambers for 15 min. Morphine preference was calculated in the
same manner as in the morphine CPP experiments.
Mice implanted with cannulae in the hippocampus, which showed
extinction of morphine CPP (see criteria above), were given dummy
injections using tailored injectors (C3151/SPC; Plastics One) to acclimate the mice to injectors and infusion tubing. On the reinstatement day,
the mice were infused with either aCSF or ifenprodil (2 g/1 l) into
their hippocampus (Zhang et al., 2013) using an infusion pump (Pump
11 Elite; Harvard Apparatus). Mice were returned to their home cage for
30 min after infusion. Mice were then injected with morphine (5 mg/kg),
then placed in the central chamber, and allowed to explore all three
chambers for 15 min to determine the time spent on the drug-paired side.
Subcellular fractionation of postsynaptic densities. Subcellular fractionation was used to isolate the postsynaptic density (PSD) for immunoblotting experiments and was performed as described previously (Morón et
al., 2007; Billa et al., 2009, 2010; Xia et al., 2011). Total hippocampi from
individual mouse brains were carefully dissected and homogenized in a
0.32 M sucrose solution containing 0.1 mM CaCl2, protease, and phosphatase inhibitors (Sigma-Aldrich). A 50 l sample of homogenate was
obtained, was diluted with 50 l of the 0.32 M sucrose solution, and was
used as the total homogenate fraction for immunoblotting experiments.
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The homogenate was adjusted to a final concentration of 1.25 M sucrose
by adding 2 M sucrose dissolved in dH2O. The homogenate was then
overlaid with a 1 M sucrose solution dissolved in 0.1 mM CaCl2 and was
centrifuged at 100,000 ⫻ g for 3 h at 4°C. Eight milliliters of synaptosomal
fraction were collected at the interface between 1.25 M/1 M sucrose solutions and was then solubilized in 20 mM Tris-HCl, pH 6.0, buffer containing 1% TX-100 for 20 min at 4°C. The synaptic junctions were
precipitated from the synaptosomal fraction by centrifugation at
40,000 ⫻ g for 30 min at 4°C. Synaptic junctions were resuspended in 20
mM Tris-Cl, pH 8, 1% TX-100, and 0.1 mM CaCl2 and incubated at 4°C
for 20 min to separate the presynaptic fraction. Finally, the PSD fraction
was precipitated by centrifugation at 40,000 ⫻ g for 30 min at 4°C,
dissolved in 1% SDS, and kept at ⫺80°C until use.
Immunoblotting. Equal amounts of either total homogenate or PSD
fractions (10 g) were loaded and separated in 10% SDS-PAGE for 120
min. Protein was then transferred to nitrocellulose membranes via electrophoresis at 4°C for 90 min. Membranes were blocked in 5% nonfat
evaporated milk for 30 min and were incubated with primary antibodies
selective to NR1 (1:500; incubated overnight at 4°C; PA3–102; Pierce),
NR2a (1:1000; incubated 1 h at room temperature; AB1555; Millipore),
or NR2b (1:1000; incubated 1 h at room temperature; catalog #75-097;
NeuroMab) or ␤-actin (1:5000; incubated 1 h at room temperature;
MAB1501; Millipore). Next, the membranes were incubated with either
IRDye 680 anti-mouse or IRDye 800 anti-rabbit (1:5000) followed by
scanning with Odyssey (LI-COR Biosciences) or with anti-rabbit HRP
(1:5000) followed by Amersham ECL Plus detection (GE Healthcare).
The pixel intensity of NR1, NR2a, NR2b, and ␤-actin was measured
using AlphaEase software, and the intensity of NR1, NR2a, and NR2b was
normalized to ␤-actin to ensure equal protein loading between groups.
␤-Actin was used as a loading control because its expression did not
change across any drug treatment for all experiments and because it is
enriched in PSD fractions (Matus et al., 1982). Morphine CPP and unpaired morphine groups were normalized to saline-treated controls to
calculate the percentage of change in intensity relative to saline-treated
controls.
Electrophysiology. Mice were decapitated immediately after the postconditioning testing phase of morphine CPP, extinction of morphine
CPP, and reinstatement of morphine CPP. Brains were quickly removed
in a semi-frozen sectioning solution that contained 175 mM sucrose, 7
mM MgCl2, 2.5 mM KCl, 1.2 mM NaH2PO4, 0.5 mM CaCl2, 26 mM
NaHCO3, and 25 mM glucose. Brains were mounted and sliced at 450 m
thickness while submerged in an ice-cold sectioning solution. Sagittally
cut slices were transferred to beakers that contained aCSF and incubated
at 30 ⫾ 1°C for at least 30 min. Slices were then transferred to the recording chamber that was maintained at 30 ⫾ 1°C, and 95% O2/5% CO2 was
bubbled continuously during dissection, incubation, and recording. A
concentric bipolar stimulating electrode was placed in the Schaffer collateral pathway to evoke synaptic responses, and a glass Ag/AgCl electrode filled with aCSF was placed in the stratum radiatum of CA1 to
record extracellular field EPSPs (fEPSPs). Slices were allowed to stabilize
for 15 min, and then a stimulus–response curve was constructed by
recording fEPSPs after stimulating the slice with increasing voltages (3–9
V). For LTP recordings, a voltage that elicited 50% of the maximum
fEPSP was used (between 5 and 7 V in all recordings). Baseline synaptic
responses were recorded for 20 min, and then LTP was induced by two
high-frequency stimulation trains (100 Hz, 1 s duration) separated by a
20 s intertrain interval. Data acquisition and analysis were performed
using Clampex and Clampfit 8.2 (Molecular Devices).
Data and statistical analyses. Results are expressed as the mean ⫾ SEM.
Data from behavioral and electrophysiological experiments with three
groups were analyzed using one-way ANOVAs, followed by Tukey’s or
Games–Howell post hoc comparisons, whereas data from immunoblotting experiments were analyzed with two-tailed unpaired Student’s t
tests. Linear regression was used to compare the slopes of fiber volley
(FV)/fEPSP ratios. Significance was set at p ⬍ 0.05. Statistical analyses of
data were generated by using Prism software (version 5.0; GraphPad
Software).

Results
Basal synaptic transmission is increased whereas
hippocampal LTP is selectively impaired after expression of
morphine CPP
To directly investigate the effects of morphine CPP on basal synaptic transmission and hippocampal LTP, mice were conditioned
in an unbiased morphine CPP paradigm that paired escalating
doses of morphine (5, 8, 10, and 15 mg/kg, s.c.) with a neutral
context, and electrophysiological changes in basal synaptic transmission and LTP were recorded immediately after CPP testing.
Mice trained in the CPP procedure showed a significant increase
in time spent in the drug conditioning chamber that was paired
with morphine relative to all other groups (Fig. 1B; n ⫽ 9 –14 per
group; F(2,30) ⫽ 12.98; p ⬍ 0.05, Tukey’s post hoc test).
After expression of morphine CPP, hippocampi were collected and prepared for use in electrophysiological field recordings. Mice that exhibited morphine CPP showed significant
increases in basal synaptic transmission (Fig. 1C; n ⫽ 4 per group;
6 V: F(2,8) ⫽ 4.30, p ⬍ 0.05, 7 V: F(2,8) ⫽ 5.49, p ⬍ 0.05; 8 V:
F(2,8) ⫽ 8.17, p ⬍ 0.01). Tukey’s post hoc comparisons revealed
the application of 6 – 8 V stimulation produced significant increases in basal synaptic transmission in morphine conditioned
mice when compared with saline conditioned mice ( p ⬍ 0.05);
no other significant differences were found between the three
groups. As a control measure, all fEPSP slopes were also plotted
against presynaptic FV amplitude to determine whether differences in basal synaptic transmission were related to differences in
the positioning of the stimulating electrode. Morphine CPP
significantly increased fEPSP slopes at similar presynaptic FV
amplitudes when compared with all other groups (Fig. 1C,
inset; n ⫽ 4 per group; linear regression comparisons; morphinepaired vs saline: F(1,38) ⫽ 45.65, p ⬍ 0.05; morphine-paired vs
morphine-unpaired, F(1,38) ⫽ 8.21, p ⬍ 0.01). These data suggest that morphine CPP selectively enhances basal synaptic
transmission, leading to significant alterations in hippocampal synaptic plasticity.
We demonstrated previously that treatment with escalating
doses of morphine can alter hippocampal synaptic plasticity associated with context-dependent behavioral sensitization (Xia et
al., 2011), but it remains unknown whether other forms of
context-dependent morphine treatment, such as morphine CPP,
also lead to changes in hippocampal synaptic plasticity. The CPP
model is suitable for examining context-dependent drug effects
and reinstatement of the conditioned responses after extinction.
Therefore, we examined changes in hippocampal LTP after the
expression of morphine CPP. Comparisons of fEPSP slopes between groups were made during the final 10 min of recording
(50 – 60 min after the start of recording). Mice that were trained
and tested for morphine place preference showed a profound and
significant decrease in hippocampal LTP (Fig. 1D; n ⫽ 3– 4 per
group; F(2,27) ⫽ 114.9, p ⬍ 0.05, Tukey’s post hoc test) when
compared with both groups.
It is possible that changes in basal synaptic transmission
and/or synaptic plasticity may be directly attributable to 24 h of
withdrawal from morphine administration instead of an effect
that was observed only when morphine was paired with a distinct
context. Therefore, an unpaired control morphine CPP group
was included that received morphine in both drug conditioning
chambers. Mice trained in the morphine-paired design had a
significant increase in place preference relative to morphineunpaired mice (Fig. 1B; p ⬍ 0.05, Tukey’s post hoc test), and
morphine-unpaired mice showed no changes in preference when
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Figure 2. Impaired LTP after morphine CPP is a consequence of the reexposure to the drug-paired chamber. A, A schematic of the experimental design is shown. B, C, Mice trained and tested for
morphine CPP that are kept at their home cages for 7 d show LTP similar to saline-treated mice. C, Shows comparisons of fEPSP slopes during the final 10 min of recording.

compared with saline controls. Furthermore, no changes in basal
synaptic transmission or LTP were observed in mice that received
unpaired morphine treatment (Fig. 1D), indicating that changes
in hippocampal synaptic plasticity observed in the morphine
CPP group are not attributable to mechanisms related to a 24 h
withdrawal from morphine exposure. Furthermore, these data
suggest that these effects on synaptic transmission and LTP are
likely not attributable to the morphine exposure itself because
mice treated in an unpaired design did not show place preference,
increased basal synaptic transmission, or impaired LTP. Together, these data suggest that alterations in basal synaptic transmission and synaptic plasticity only occur in animals that have
acquired and are expressing a drug– context association.
Finally, we conducted studies to examine whether the impaired LTP is observed after withdrawal of morphine conditioning. To this end, a separate group of mice were conditioned and
tested for morphine CPP as described above. After the CPP test,
mice were kept in their home cages for 7 d (Fig. 2A). We found
that LTP in morphine-treated mice was indistinguishable from
saline-injected mice 7 d after morphine conditioning (Fig. 2 B, C;
n ⫽ 5– 6 per group), indicating that alterations in synaptic plasticity in the hippocampus are no longer observed when animals
are not reexposed to the previously drug-paired chambers 7 d
after the initial CPP test.
Increased synaptic NR1 and NR2b expression is associated
with expression of morphine place preference
Changes to basal synaptic transmission and hippocampal LTP
that occur after the expression of morphine CPP may be attributable to changes in the expression of NMDARs, because
NMDARs are essential for hippocampal synaptic plasticity
(Muller et al., 1988; Shapiro and Eichenbaum, 1999; Miyamoto,
2006). Therefore, we next determined whether changes in
NMDARs in the total homogenate and PSD were present biochemically after the expression of morphine CPP. Mice that were
trained and tested in morphine CPP had increased expression of

NR1 and NR2a in the total homogenate when compared with
saline controls (Fig. 3A; n ⫽ 4 – 8 per group; NR1, t(13) ⫽ ⫺2.84,
p ⬍ 0.05; NR2a, t(13) ⫽ ⫺2.57, p ⬍ 0.05), whereas we found that
expression levels of all three subunits were increased in the PSD
(Fig. 3B; n ⫽ 4 – 8 per group; NR1, t(14) ⫽ ⫺3.37, p ⬍ 0.01; NR2a,
t(6) ⫽ ⫺3.10, p ⬍ 0.05; NR2b, t(6) ⫽ ⫺2.88, p ⬍ 0.05). In contrast,
mice that were conditioned and tested with an unpaired design
only showed increased NR2a expression in the total homogenate
(Fig. 3C; n ⫽ 4 – 8 per group; NR2a, t(6) ⫽ ⫺2.97, p ⬍ 0.05) and
PSD (Fig. 3D; n ⫽ 4 – 8 per group; NR2a, t(14) ⫽ ⫺3.67, p ⬍ 0.01)
relative to saline-treated mice. Given that NR2a expression in the
total homogenate was increased in both morphine CPP and unpaired morphine groups, it is likely that this increase we measured is attributable to either treatment with morphine or the
24 h withdrawal from morphine exposure. However, increased
expression of NR1 and NR2b in the PSD was only observed in
morphine-conditioned mice, strongly suggesting that the alterations of NR1 and NR2b occur only when morphine is directly
paired with a novel context. Together, these data suggest that the
expression of morphine CPP is associated with a selective increase in synaptic NR1 and NR2b expression, whereas increases
in total synaptic NR2a expression occur as a direct result of morphine exposure.
Hippocampal LTP is impaired after the extinction of
morphine CPP
The results from the previous experiments suggest that morphine
CPP is associated with increased basal synaptic transmission, disrupted LTP, and increased synaptic NR1 and NR2b expression
(Table 1). However, it is also possible that these alterations in
synaptic plasticity and NMDAR expression may also be observed
after extinction of morphine CPP, because extinction training
engages the learning of a new drug– environment association.
Therefore, we conditioned mice in an unbiased morphine CPP
procedure as described above, and morphine place preference
was extinguished with repeated extinction sessions (five times, 30
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min each) in which saline was administered in the morphine-paired chamber in
place of morphine (Fig. 4A). Mice conditioned in the morphine CPP procedure
exhibited increased preference for the
morphine-paired compared with all other
groups (Fig. 4B; n ⫽ 10 –16 per group;
F(2,35) ⫽ 16.98, p ⬍ 0.05). In contrast, no
significant preference for the former
drug-paired context was observed when
mice were tested for preference after repeated extinction training with saline
injections.
Electrophysiological recordings were
conducted immediately after the behavioral
test extinction CPP testing. Recordings of
basal synaptic transmission revealed no differences between groups when fEPSPs were
directly examined and when fEPSPs were
normalized to presynaptic FV amplitude
(Fig. 4C and inset in C). Although no
changes in basal synaptic transmission were
observed, recordings of hippocampal LTP
revealed that mice showing extinguished
morphine CPP had significantly impaired
LTP compared with saline-treated and unpaired morphine groups (Fig. 4D; n ⫽ 3–5
per group; F(2,27) ⫽ 157.3, p ⬍ 0.05 and p ⬍
0.01, respectively). In contrast, mice that received unpaired morphine treatment and
extinction training exhibited robust LTP
that was not significantly different from
saline-treated mice, suggesting that the disrupted LTP observed after extinction of
morphine CPP is not attributable to the 1
week of withdrawal from unpaired morphine treatment. These data demonstrate
that hippocampal LTP is impaired after extinction of morphine CPP. Given that extinction reflects an active learning process,
similar to that during morphine CPP, these
data suggest that disrupted LTP may be related to the acquisition of a drug– environment association.
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synaptic plasticity that were observed after Figure 3. Alterations in synaptic NMDAR subunit expression after expression of morphine CPP. A, After the expression of
morphine CPP expression and extinction. morphine CPP, NR1 and NR2a NMDAR subunits were increased in the total homogenate (n ⫽ 4 – 8 per group; unpaired t test; *p ⬍
Using synaptosomal preparations, we 0.05). B, NR1, NR2a, and NR2b subunit expression was increased at the PSD (n ⫽ 4 – 8 per group; unpaired t test; *p ⬍ 0.05). C,
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tered after morphine CPP extinction
extinguished from unpaired morphine treatment compared with
training or in the morphine-unpaired group that underwent exsaline-treated mice (Fig. 5D). Together, these results indicate that
tinction training (Fig. 5 A, C; n ⫽ 4). Furthermore, expression of
extinction from morphine CPP is associated with increased synNR2b in the PSD was significantly increased after extinction
aptic expression of the NR2b NMDAR subunit. Interestingly,
of morphine CPP relative to saline-injected mice (Fig. 5B; NR2b,
this increase was absent in mice that received similar extinction
t(6) ⫽ 2.879; F(3,3) ⫽ 1.801, p ⬍ 0.05; n ⫽ 4). In contrast, no
training but underwent morphine-unpaired treatment. In addichanges in NMDAR expression were observed in mice that were
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Figure 4. Extinction of morphine CPP is associated with impaired LTP. A, A schematic of the experimental design is shown for the training and testing of morphine CPP and extinction of morphine CPP. B,
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were observed in fEPSP slope. Insets show fEPSP/FV relationships. D, The extinction of morphine CPP was associated with impaired LTP when compared with saline-treated mice and morphine-unpaired mice
(n ⫽ 3–5 per group; one-way ANOVA; *p ⬍ 0.05, **p ⬍ 0.01). Insets show comparisons of fEPSP slopes during the final 10 min of recording.

tion, these data further support the notion that the effects we
observed are not attributable to 1 week withdrawal from morphine treatment.
Drug-induced reinstatement of morphine CPP is associated
with increased hippocampal LTP
Although we found that extinction of morphine CPP is associated
with disrupted LTP, it is unknown whether the reinstatement of
morphine CPP with a priming dose of morphine could also lead
to alterations in LTP. Therefore, mice were conditioned and
tested in an unbiased morphine CPP procedure and then morphine CPP was extinguished as described above (for a description
of animal groups, see Fig. 6A). Twenty-four hours after testing for
the extinction of morphine CPP, mice received a subcutaneous
priming dose of 5 mg/kg morphine and were allowed to explore
all three chambers for 15 min (morphine-paired/morphine rein)
while preference for the drug-paired chamber was recorded. Additionally, control groups were included that received only saline
during CPP and extinction training but were administered 5
mg/kg morphine during reinstatement (saline group) and a
group that received unpaired morphine treatment during CPP,
saline during the extinction phase, and 5 mg/kg morphine during
reinstatement (morphine-unpaired group). A final group was
included that received morphine CPP, saline during extinction,
but received saline during reinstatement (morphine-paired/saline rein). Mice in the morphine-paired/morphine and morphine-paired/saline groups both showed a significant preference
for the morphine-paired chamber during the test for CPP,
whereas the other control groups did not form a significant place
preference for a particular context (Fig. 6B; n ⫽ 8 –12 per group;
F(3,38) ⫽ 8.73, p ⬍ 0.05). After extinction, no significant preference score was observed in any of the four groups. Morphine CPP
extinguished mice that received a priming dose of morphine
showed significant reinstatement to morphine CPP relative to all

other groups (Fig. 6B; n ⫽ 8 –12 per group; F(3,38) ⫽ 12.21, p ⬍
0.05). In contrast, mice in the morphine CPP/saline group
showed no change in their preference scores after a priming
dose of saline, indicating a selective effect of morphine-prime
injection on reinstatement of CPP.
After reinstatement of morphine CPP, hippocampi were dissected and sliced for use in electrophysiological experiments. No
changes in basal synaptic transmission were observed between
groups when fEPSPs were directly examined (Fig. 6C) or when
fEPSPs were normalized to presynaptic FV amplitude. Recordings of hippocampal LTP after reinstatement or morphine CPP
revealed that mice in the morphine-paired/saline group, which
did not show reinstatement of morphine CPP, had significantly impaired LTP when compared with all other groups (Fig. 6D; n ⫽ 3– 4
per group; F(3,36) ⫽ 37.3, p ⬍ 0.05). In contrast, mice in the morphine CPP/morphine group showed reinstatement of morphine CPP and had LTP that was indistinguishable from LTP
observed in saline-treated mice and morphine-unpaired mice.
Together, these data suggest that morphine-primed reinstatement may lead to a restoration of hippocampal LTP, which in
turn may be a critical synaptic mechanism for the reinstatement
of expressed morphine CPP.
We observed that NR2b expression was increased after the
expression and the extinction of morphine CPP, suggesting a
possible role for NR2b in reinstatement of morphine CPP. To
investigate this, mice were bilaterally cannulated in the hippocampus. These mice were conditioned and tested in an unbiased morphine CPP procedure (Fig. 7A) and then morphine CPP
was extinguished as described above. Twenty-four hours after
testing for the extinction of morphine CPP, mice were infused
with either aCSF or ifenprodil (2 g/1 l), placed in the home
cage for 30 min, and then received a subcutaneous priming dose
of 5 mg/kg morphine. Mice were then allowed to explore all three
chambers for 15 min while preference for the drug-paired cham-
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Dissecting the association between hippocampal-dependent mechanisms, for drugs
such as morphine, with environmental
stimuli are an important and understudied
component of addiction. Drug-associated
environmental stimuli can lead to cravings,
which in turn contribute to maintenance of
drug use or lead to relapse (Daglish et al.,
2001; See, 2002; Rukstalis et al., 2005;
Gould, 2006). Previous studies have indicated that alterations of glutamatergic transmission in the hippocampus are crucial for
behavioral measures of context-dependent
morphine treatment, such as morphine
CPP, behavioral sensitization, and cue or
context-induced reinstatement of selfadministration (Bossert et al., 2006; Zarrindast et al., 2007; LaLumiere and Kalivas,
2008; Zhou and Kalivas, 2008; Knackstedt
and Kalivas, 2009; Xia et al., 2011), but it has
remained unclear whether morphine CPP is
associated with changes to NMDARdependent forms of synaptic plasticity, such
as LTP. In the present study, we demonstrate for the first time that morphine CPP,
extinction of morphine CPP, and reinstatement of morphine CPP are all associated
with robust changes in hippocampal synaptic plasticity. Expression of morphine CPP
was associated with increased basal synaptic
transmission, impaired hippocampal LTP,
and increased synaptic expression of the
NR1 and NR2b NMDAR subunits. These
changes in NMDAR expression and synaptic plasticity were not observed when morphine treatment was not associated with a
specific context. After extinction of morphine CPP, hippocampal LTP was impaired
and synaptic NR2a and NR2b expression
was increased, suggesting that some changes
in hippocampal synaptic plasticity and synaptic NMDAR expression observed during
expression of morphine CPP may be similar

NR1

Homogenate
kDa
Saline Morphine
120

160
140
120
100
80
60
40
20
0

NR2b

*

NR2a

NR2b

Saline
Morphine Unpaired

C

NR1

NR2a

Saline
Morphine Paired

NR1

Homogenate
Saline Morphine kDa
120

NR2a

180

NR2b

166

Actin

43

150
Protein Expression
(% of Saline)

Discussion

Saline
Morphine Paired

A

100

50

0
NR1

NR1

NR2a

NR2b

Saline
Morphine Unpaired

D
PSD
Saline Morphine kDa
120

NR2a

180

NR2b

166

Actin

43

140
Protein Expression
(% of Saline)

ber was recorded. Mice infused with ifenprodil did not show reinstatement to
morphine CPP (Fig. 7B; n ⫽ 5 per group;
F(4,3) ⫽ 2.763, p ⬍ 0.05), whereas the
aCSF-injected control groups showed a
typical robust morphine-primed reinstatement of CPP. In addition, locomotor
activity was measured during the reinstatement phase, and no significant difference in activity was observed between mice
infused with aCSF or ifenprodil, demonstrating that the ifenprodil inhibition of reinstatement is not attributable to decreased
activity after infusion of drug (Fig. 7C). Together, these data suggest that blockade of
NR2b with local administration of ifenprodil in the hippocampus prevents
morphine-induced reinstatement.
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Figure 5. Alterations in synaptic NMDAR subunit expression after extinction of morphine CPP. A, B, After extinction of morphine
CPP, NR2b NMDAR subunit expression was increased at the PSD (n ⫽ 4 per group; unpaired t test; *p ⬍ 0.05). C, D, In contrast,
mice showed no changes in NMDAR subunit expression after extinction from a design of unpaired morphine treatment.
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Figure 6. Reinstatement of morphine CPP is associated with robust enhancement of LTP. A, A schematic of the experimental design is shown for the training and testing of morphine CPP,
extinction of morphine CPP, and reinstatement of morphine CPP. B, Drug-induced reinstatement of morphine CPP. Mice exhibited a CPP when morphine was paired with a novel context
(morphine-paired; n ⫽ 8 –12 per group; one-way ANOVA; *p ⬍ 0.05), whereas no preference change was observed after extinction of morphine CPP. After extinction of morphine CPP, mice
received a priming dose of either saline or morphine and were allowed to explore all three chambers. Mice that received a priming dose of morphine showed a significant preference for the
morphine-paired chamber relative to all other groups (n ⫽ 8 –12 per group; one-way ANOVA; *p ⬍ 0.05). C, No changes were observed in fEPSP slope after reinstatement of morphine CPP. Insets
show fEPSP–FV relationships. D, The reinstatement of morphine CPP was associated with LTP was similar to saline-treated mice and morphine-unpaired mice. In contrast, mice that received a saline
priming dose did not exhibit reinstatement of morphine CPP and had disrupted LTP when compared with all other groups (n ⫽ 3– 4 per group; one-way ANOVA; *p ⬍ 0.05, **p ⬍ 0.01). Insets show
comparisons of fEPSP slopes during the final 10 min of recording.

to those observed after extinction training (Table 1). Interestingly,
hippocampal LTP was indistinguishable from saline controls when a
priming dose of morphine was used to reinstate morphine CPP. In
contrast, a priming injection of saline did not reinstate morphine
CPP and was associated with disrupted LTP. Finally, the blockade of
the NR2b subunit with ifenprodil in the hippocampus prevented
morphine-induced reinstatement of CPP.
The expression of CPP is a widely used pavlovian behavioral paradigm that models the association between the rewarding effects of
drugs and contextual stimuli that occur in opioid addicts (Bardo and
Bevins, 2000). Results from both the present study and previous
findings suggest that hippocampal glutamatergic transmission may
be crucial for the development and maintenance of contextdependent associative behaviors. In the present study, NR1 and
NR2a NMDAR subunit expression was increased in the homogenate
after the expression of morphine CPP, whereas expression of NR1,
NR2a, and NR2b was increased in the PSD. In contrast, only NR2a
expression was increased when morphine treatment was not paired
with a particular context. Thus, the increased NR2a expression observed in the morphine CPP group and the unpaired morphine
group suggests that this change in NMDAR subunit expression may
be attributable to treatment with morphine or 24 h withdrawal from
morphine. The results reported here are similar to previous studies
that report an increase in NR2b subunit expression in the hippocampus or nucleus accumbens after morphine CPP or that have used a
selective NR2b antagonist (ifenprodil) to block morphine CPP (Ma
et al., 2006, 2011b; Xu et al., 2012). However, no studies to date have
directly determined how hippocampal NMDAR expression is affected in the PSD after a morphine CPP paradigm. Furthermore,

previous studies using other behavioral models have demonstrated
that context-dependent morphine treatment requires glutamatergic
transmission in the hippocampus (Ma et al., 2006, 2011b; Kao et al.,
2011; Xu et al., 2012). Studies of other drugs of abuse, such as cocaine, heroin, and nicotine, indicate that glutamatergic transmission
may also be important for drug– context associations (Gould and
Lewis, 2005; Bossert et al., 2006; Crombag et al., 2008), but this
hypothesis requires additional examination.
In the present study, we observed that morphine CPP was associated with changes in NMDAR expression, which may also lead to
alterations of hippocampal synaptic plasticity. After the expression
of morphine CPP, basal synaptic transmission was enhanced and
LTP was significantly impaired in the hippocampus. These effects
were not observed when morphine was not paired with a specific
context. Therefore, it is unlikely that changes in hippocampal synaptic plasticity are attributable to withdrawal from unpaired morphine treatment. Furthermore, we also observed that this reduction
in LTP was not observed when animals were kept in their home cages
7 d after the initial morphine CPP test, suggesting that the alterations
in synaptic plasticity may be a consequence of the reexposure to the
drug-paired context. The increased basal synaptic transmission observed after morphine CPP expression may in fact be related to increased NR1, NR2a, and NR2b subunit expression observed in the
PSD. Consistent with this interpretation, previous studies have reported that increased NMDAR subunit expression at the synapse
could lead to increased calcium permeability and could potentiate
hippocampal synaptic responses (MacDermott et al., 1986; Jahr and
Stevens, 1987; Malenka et al., 1988). Furthermore, it is possible that
increased synaptic NMDAR expression after morphine CPP could
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Figure 7. Local antagonism of the NR2b subunit in the hippocampus blocks reinstatement of morphine CPP. A, A schematic of the experimental design is shown for the training and testing of
morphine CPP, extinction of morphine CPP, ifenprodil infusion, and reinstatement of morphine CPP. B, Drug-induced reinstatement of morphine CPP. After extinction of morphine CPP, mice were
infused with either aCSF or ifenprodil 30 min before a priming dose of morphine and were allowed to explore all three chambers. Ifenprodil significantly blocked morphine-primed reinstatement
(n ⫽ 5 per group; Student’s t test; *p ⬍ 0.05). C, Locomotor activity measured in 5 min bins during reinstatement phase. Data represent mean ⫾ SEM distance traveled (centimeters), n ⫽ 5. D,
Schematic of three sections spanning the target region of cannulae placement; filled black circles represent cannulae placement in each mouse (n ⫽ 5 per group).
Table 1. Changes in synaptic plasticity during morphine expression, extinction, and reinstatement
Expression
Extinction
Reinstatement

fEPSP
LTP
Homogenate
NR1
NR2a
NR2b
PSD
NR1
NR2a
NR2b

Morphine
paired

Morphine
unpaired

Morphine
paired

Morphine unpaired

Saline/morphine

Morphine
paired/saline

Morphine paired/morphine

Morphine unpaired/morphine

1
2

⫽
⫽

⫽
2

⫽
⫽

⫽
⫽

⫽
2

⫽
⫽

⫽
⫽

1
1
⫽

⫽
1
⫽

⫽
⫽
⫽

⫽
⫽
⫽

1
1
1

⫽
1
⫽

⫽
⫽
1

⫽
⫽
⫽

Summary of changes in fEPSP, LTP, and NMDAR subunit expression during the three phases of morphine CPP, extinction, and reinstatement.

lead to a saturation of NMDARs at the synapse, which in turn could
produce an occlusion of LTP in the hippocampus (Nicoll and
Malenka, 1999). Conversely, a growing body of evidence suggests
that the NR2b subunit plays a critical role in plasticity (Barria and
Malinow, 2005; Foster et al., 2010; Kiraly et al., 2011). Indeed, it has
been described that the NR2b subunit forms a complex with CaMKII and that reduction of this complex should produce a disruption
of synaptic plasticity (Sanhueza et al., 2011). Based on our findings,
one possible explanation is that the increase in the expression of
NR2b at the PSD observed after the expression and the extinction
of morphine CPP could interfere with the formation of the
NR2b–CaMKII complex and thus disrupt the induction and
maintenance of LTP. Together with our current results, this suggests that context-dependent morphine treatment produces enhanced basal synaptic transmission and impaired LTP, and these
effects may be attributable to enhanced glutamatergic transmission at hippocampal synapses.
The extinction of drug-associated contextual memories may help
reduce the likelihood of relapse (Peters et al., 2008b), but changes in

neural function that are resistant to extinction are important because
these changes could lead to failure of extinction and may facilitate
relapse of drug-seeking behavior (Ovari and Leri, 2008; Peters et al.,
2008a). We found that, after extinction of morphine CPP, hippocampal LTP was impaired and NR2b subunit expression was increased in the PSD. In contrast, no changes in LTP or NMDAR
subunit expression were observed when mice received unpaired
morphine treatment. Although the results observed during extinction were similar to those after expression of morphine CPP, basal
synaptic transmission was not altered after extinction but it was increased after expression of morphine CPP. The lack of effect on basal
transmission after extinction training may be attributable to the fact
that, unlike NR2b, synaptic levels of NR2a subunits returned to normal. It has been shown previously by our laboratory and others that
the NR2a subunit is a major contributor to NMDAR currents in
CA1 hippocampus (Bartlett et al., 2007; Foster et al., 2010; Fakira et
al., 2013). Thus, the fact that no changes in NR2a expression were
observed after extinction training may account for the lack of effect
on basal synaptic transmission.
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Because extinction training reflects an active learning process
that may not be different from that which is engaged when animals
are acquiring the initial morphine– environment association, it is
not surprising that the impaired LTP is observed after both the expression and extinction of CPP. However, it is likely that the impaired LTP observed after extinction may require different neural
mechanisms from those required for the expression of CPP. This is
because only NR2b subunit expression was increased after extinction and basal synaptic transmission remained unchanged.
Reinstatement of morphine CPP can be used as a high throughput behavioral model of relapse to drug use. In the present study, a
priming dose of morphine was sufficient to reinstate morphine CPP,
but the infusion of the NMDAR blocker ifenprodil directly into the
hippocampus blocked morphine reinstatement. These behavioral
findings correlate with the increase in NR2b, which may be associated with changes/restoration of LTP via CaMKII (Sanhueza et al.,
2011). Interestingly, recordings of hippocampal LTP in mice that
showed morphine-primed reinstatement were similar to saline controls. In contrast, mice showed impaired hippocampal LTP after a
priming dose of saline that did not lead to reinstatement of morphine CPP. This restoration of LTP after morphine-induced reinstatement may be attributable to the fact that hippocampal plasticity
becomes “opioid dependent” after drug conditioning. Indeed, previous studies have shown that long-term chronic morphine treatment leads to impaired hippocampal LTP (Pu et al., 2002; Bao et al.,
2007). Interestingly, this impaired LTP was restored by reexposure
of the animals to opioids, suggesting that this hippocampal plasticity
has been adapted to the presence of opioids. Given the role of the
cAMP pathway in the synaptic effects of opioids, Pu et al., (2002)
show that this opioid-dependent hippocampal plasticity is regulated
by the activation of the cAMP pathway such that overactivation of
the cAMP pathway after chronic opioid exposure seems to be responsible for the reduction in LTP. Overactivation of this pathway
can then be suppressed by the reexposure to the opioid, which results
in restoration of LTP.
Studies of heroin self-administration have revealed that mGluR
agonists and AMPA antagonists in the nucleus accumbens can block
reinstatement of heroin self-administration (Bossert et al., 2006;
LaLumiere and Kalivas, 2008; Zhou and Kalivas, 2008). Together,
these results suggest that hippocampal glutamatergic signaling may
be important for both reinstatement of morphine CPP and changes
in hippocampal LTP that occur after morphine CPP. Investigations
of the mechanisms underlying these changes to behavior and synaptic plasticity are important extensions of the current work. A better
understanding of the molecular mechanisms involved in LTP impairment observed during morphine CPP is necessary to identify
molecular targets that enhance the extinction of morphine CPP or
prevent reinstatement of CPP. These studies provide useful information for the potential development of new pharmacotherapeutics for
treating opioid addiction.
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